We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.6B
AUM Growth
+$2.73M
Cap. Flow
-$57.6M
Cap. Flow %
-3.6%
Top 10 Hldgs %
27.48%
Holding
400
New
43
Increased
63
Reduced
145
Closed
50

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
2
NEE icon
NextEra Energy
NEE
+$19.1M
3
DD icon
DuPont de Nemours
DD
+$14.5M
4
MMM icon
3M
MMM
+$13.4M
5
BUD icon
AB InBev
BUD
+$9.22M

Top Sells

Rank Stock Value
1
WLL
Whiting Petroleum Corporation
WLL
+$33.7M
2
PRGO icon
Perrigo
PRGO
+$25.8M
3
GE icon
GE Aerospace
GE
+$19.6M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M
5
UPS icon
United Parcel Service
UPS
+$12.4M

Sector Composition

Rank Sector Weight
1 Industrials 22.78%
2 Healthcare 12.8%
3 Consumer Staples 10%
4 Consumer Discretionary 9.98%
5 Technology 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
76
Baidu
BIDU
$36.5B
$1.54M 0.1%
6,750
-1,450
-18% -$332K
EMBJ
77
Embraer S.A. ADS
EMBJ
$12.1B
$1.47M 0.09%
40,000
– –
ALV icon
78
Autoliv
ALV
$9.09B
$1.43M 0.09%
18,738
– –
NVS icon
79
Novartis
NVS
$301B
$1.43M 0.09%
17,195
– –
SNA icon
80
Snap-on
SNA
$21.2B
$1.42M 0.09%
10,350
+4,850
+88% +$636K
MRO
81
DELISTED
Marathon Oil Corporation
MRO
$1.39M 0.09%
+49,050
New +$1.56M
UN
82
DELISTED
Unilever NV New York Registry Shares
UN
$1.37M 0.09%
35,057
+4,950
+16% +$194K
RDY icon
83
Dr. Reddy's Laboratories
RDY
$9.85B
$1.36M 0.09%
135,000
+25,000
+23% +$263K
LUX
84
DELISTED
Luxottica Group
LUX
$1.36M 0.09%
25,003
-8,000
-24% -$412K
CNQ icon
85
Canadian Natural Resources
CNQ
$98.6B
$1.33M 0.08%
88,844
+6,619
+8% +$108K
SLG icon
86
SL Green Realty
SLG
$3.81B
$1.28M 0.08%
11,110
– –
WTS icon
87
Watts Water Technologies
WTS
$11.5B
$1.27M 0.08%
20,100
+15,000
+294% +$912K
NVO
88
Novo Nordisk
NVO
$228B
$1.27M 0.08%
60,050
– –
TM icon
89
Toyota
TM
$227B
$1.25M 0.08%
10,000
-2,000
-17% -$240K
HAL icon
90
Halliburton
HAL
$26.4B
$1.18M 0.07%
29,950
+23,550
+368% +$1.15M
MDLZ icon
91
Mondelez International
MDLZ
$80.5B
$1.16M 0.07%
32,000
+18,000
+129% +$655K
KKR icon
92
KKR & Co
KKR
$90.7B
$1.16M 0.07%
+50,000
New +$1.1M
TEVA icon
93
Teva Pharmaceuticals
TEVA
$41.2B
$1.15M 0.07%
20,000
-53,900
-73% -$3M
DEO icon
94
Diageo
DEO
$49.5B
$1.14M 0.07%
10,005
-1,375
-12% -$160K
TSM icon
95
TSMC
TSM
$2.09T
$1.12M 0.07%
50,053
-5,000
-9% -$109K
CMA
96
DELISTED
Comerica
CMA
$1.08M 0.07%
+23,050
New +$1.08M
GLOP
97
DELISTED
GASLOG PARTNERS LP
GLOP
$1.03M 0.06%
+41,000
New +$1.07M
AVGO icon
98
Broadcom
AVGO
$1.85T
$1.01M 0.06%
100,000
-100,000
-50% -$893K
RDS.A
99
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1M 0.06%
15,000
-5,000
-25% -$346K
RY icon
100
Royal Bank of Canada
RY
$292B
$967K 0.06%
14,000
– –
2 3
4
5 6

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q4 2014 Portfolio in Review

As of Q4 2014, R.H. Bluestein & Co held 400 positions worth $1.6B, up 0.17% from $1.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

R.H. Bluestein & Co withdrew a net $57.6M in Q4 2014, closing 50 positions and reducing 145 holdings. Its most notable exit was Whiting Petroleum Corporation, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, R.H. Bluestein & Co opened a new position in Axon Enterprise worth $10.2M.

  • R.H. Bluestein & Co's largest Q4 2014 buy was Axon Enterprise: 385,499 shares worth $10.2M.
  • R.H. Bluestein & Co added most to Johnson & Johnson in Q4 2014, an estimated $20.3M increase.
  • R.H. Bluestein & Co's biggest Q4 2014 reduction was Perrigo, cutting an estimated $25.8M.
  • R.H. Bluestein & Co fully exited Whiting Petroleum Corporation in Q4 2014, selling an estimated $33.7M.
  • R.H. Bluestein & Co's ten largest holdings make up 27% of its $1.6B portfolio in Q4 2014.
  • R.H. Bluestein & Co opened 43 new positions and closed 50 in Q4 2014.
  • R.H. Bluestein & Co's portfolio value rose 0.17% quarter-over-quarter to $1.6B.

Based on R.H. Bluestein & Co's 13F filing for Q4 2014, filed 12 Feb 2015.